apifystats
Log in Start free
Actor/nexgendata

Korea IPO Pipeline Tracker — 공모주 API

FinanceKorea Exchange (KRX)DART (Korean FSS)

Track the Korea IPO pipeline and upcoming new listings. Clean JSON for analysts, quants and AI agents.

Publisher description, verbatim
Last 7 dayson this actor

No changes seen in the last 7 days.

The morning one happens, followers hear first.Follow this actor
Key figures30 readings
Price / 1k$100.00per 1,000 ipo-record
Users / 30d0→ 0 over 30 readings
Users, all time1→ 0 over 30 readings
Runs / 30d0not enough history for a trend
Runs / user / mo—runs per monthly user
Standing
#4of 5

on Korea Exchange (KRX), by users in the last 30 days among actors classified to this platform.

Recorded changes

No price, README, schema or grade changes in the last 30 days · followers get the next one by email.

History

30 readings since 2026-08-27
Users / 30d30 readings
08-27→ 009-25
Users, all time30 readings
08-27→ 009-25
Standing30 readings
08-27↑ 109-25

Alternatives on Korea Exchange (KRX)

The actors either side of #4 of 5, ranked by users in the last 30 days. Same platform, adjacent adoption — the comparable set.

all 5 on Korea Exchange (KRX) →
Sort
#ActorGradePrice / 1kUsers /30dSuccessRatingAgeFresh
1
Korea KIND Disclosures — 상장공시 APInexgendata
—RES$50.00 /1k23 total——4mfresh
2
KRX Stock Scraper — Korean Market Data for Global Investorshuggable_quote
—RES$5.00 /1k119 total——5maging
3
KOSPI Korea Stock Screener — 한국 주식 Data APInexgendata
—RES$50.00 /1k13 total——5maging
4
Korea IPO Pipeline Tracker — 공모주 APInexgendata
—EVT$100 /1k ipo-record01 total——4magingThis
5
Korea KRX Short Selling — 공매도 APInexgendata
—EVT$100 /1k short-record01 total——4maging

Follow this actor, compare it against its rivals, and get every overnight change in one morning report.

Publish it yourself? Claim your publisher page and its full history is yours free, forever.

Open in the app Claim this page

Numbers on this page are measured only by an independent census of the Apify Store — not self-reported. Not indexed: too little has happened to this actor for us to have anything worth saying yet.